267 related articles for article (PubMed ID: 1353535)
21. Clinical application of DNA analysis in a family with OTC deficiency.
McClead RE; Rozen R; Fox J; Rosenberg L; Menke J; Bickers R; Morrow G
Am J Med Genet; 1986 Nov; 25(3):513-8. PubMed ID: 2878615
[TBL] [Abstract][Full Text] [Related]
22. Mutations and polymorphisms in the human ornithine transcarbamylase gene.
Tuchman M; Jaleel N; Morizono H; Sheehy L; Lynch MG
Hum Mutat; 2002 Feb; 19(2):93-107. PubMed ID: 11793468
[TBL] [Abstract][Full Text] [Related]
23. Ornithine transcarbamylase deficiency: ten new mutations and high proportion of de novo mutations in heterozygous females.
Oppliger Leibundgut E; Liechti-Gallati S; Colombo JP; Wermuth B
Hum Mutat; 1997; 9(5):409-11. PubMed ID: 9143919
[No Abstract] [Full Text] [Related]
24. Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency.
Cavicchi C; Malvagia S; la Marca G; Gasperini S; Donati MA; Zammarchi E; Guerrini R; Morrone A; Pasquini E
J Pharm Biomed Anal; 2009 Jul; 49(5):1292-5. PubMed ID: 19359120
[TBL] [Abstract][Full Text] [Related]
25. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
[TBL] [Abstract][Full Text] [Related]
26. Identification of new mutations in the ornithine transcarbamylase (OTC) gene in Korean families.
Yoo HW; Kim GH; Lee DH
J Inherit Metab Dis; 1996; 19(1):31-42. PubMed ID: 8830175
[TBL] [Abstract][Full Text] [Related]
27. [DNA diagnosis of ornithine transcarbamylase deficiency by PCR method].
Matsuura T; Matsuda I
Tanpakushitsu Kakusan Koso; 1990 Dec; 35(17):3113-9. PubMed ID: 2287729
[No Abstract] [Full Text] [Related]
28. H intragenic polymorphisms and haplotype analysis in the ornithine transcarbamylase (OTC) gene and their relevance for tracking the inheritance of OTC deficiency.
Climent C; Rubio V
Hum Mutat; 2002 Nov; 20(5):407-8. PubMed ID: 12402347
[TBL] [Abstract][Full Text] [Related]
29. A novel two-nucleotide deletion in the ornithine transcarbamylase gene causing fatal hyperammonia in early pregnancy.
Schimanski U; Krieger D; Horn M; Stremmel W; Wermuth B; Theilmann L
Hepatology; 1996 Dec; 24(6):1413-5. PubMed ID: 8938172
[TBL] [Abstract][Full Text] [Related]
30. Toward a molecular understanding of ornithine transcarbamylase deficiency.
Fox JE; Rosenberg LE
Adv Neurol; 1988; 48():71-81. PubMed ID: 2891259
[No Abstract] [Full Text] [Related]
31. Ornithine transcarbamylase (OTC) deficiency in a female patient with a de nova deletion of the paternal X chromosome.
Slomski R; Braulke I; Behrend C; Schröder E; Colombo JP; Reiss J
Hum Genet; 1992 Aug; 89(6):632-4. PubMed ID: 1511981
[TBL] [Abstract][Full Text] [Related]
32. Maternal gonadal mosaicism causing ornithine transcarbamylase deficiency.
Bowling F; McGown I; McGill J; Cowley D; Tuchman M
Am J Med Genet; 1999 Aug; 85(5):452-4. PubMed ID: 10405441
[TBL] [Abstract][Full Text] [Related]
33. Carbamyl phosphate synthetase and ornithine transcarbamylase activities in enzyme-deficient human liver measured by radiochromatography and correlated with outcome.
Tuchman M; Tsai MY; Holzknecht RA; Brusilow SW
Pediatr Res; 1989 Jul; 26(1):77-82. PubMed ID: 2771513
[TBL] [Abstract][Full Text] [Related]
34. Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency.
Gyato K; Wray J; Huang ZJ; Yudkoff M; Batshaw ML
Ann Neurol; 2004 Jan; 55(1):80-6. PubMed ID: 14705115
[TBL] [Abstract][Full Text] [Related]
35. Evidence for x-linked dominant inheritance of ornithine transcarbamylase deficiency.
Short EM; Conn HO; Snodgrass PJ; Campbell AG; Rosenberg LE
N Engl J Med; 1973 Jan; 288(1):7-12. PubMed ID: 4681915
[No Abstract] [Full Text] [Related]
36. Partial ornithine transcarbamylase deficiency in females: diagnosis by an immunohistochemical method.
Hayasaka K; Metoki K; Ishiguro S; Kato S; Chiba T; Hirooka M; Kikuchi M; Kurobane I; Narisawa K; Tada K
Eur J Pediatr; 1987 Jul; 146(4):370-2. PubMed ID: 3308467
[TBL] [Abstract][Full Text] [Related]
37. The biochemical and molecular spectrum of ornithine transcarbamylase deficiency.
Tuchman M; Morizono H; Rajagopal BS; Plante RJ; Allewell NM
J Inherit Metab Dis; 1998; 21 Suppl 1():40-58. PubMed ID: 9686344
[TBL] [Abstract][Full Text] [Related]
38. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.
Batshaw ML; Msall M; Beaudet AL; Trojak J
J Pediatr; 1986 Feb; 108(2):236-41. PubMed ID: 3944708
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of clinical features, biochemical analysis and gene mutations in one Chinese pedigree with neonatal-onset ornithine transcarbamylase deficiency].
Sun WH; Yang Y; Zhang YP; Li XT; Zhang M; Cao Y; Wang Y
Zhonghua Er Ke Za Zhi; 2011 May; 49(5):356-60. PubMed ID: 21624287
[TBL] [Abstract][Full Text] [Related]
40. Prenatal molecular evaluation of six fetuses in four unrelated Korean families with ornithine transcarbamylase deficiency.
Yoo HW; Kim GH
J Korean Med Sci; 1998 Apr; 13(2):179-85. PubMed ID: 9610619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
